Pascal Soriot

pivot change turnaround direction walk away
Biotech

AstraZeneca CEO defends 'fantastic' Alexion buy as halts drug

AstraZeneca ended development of vemircopan, triggering a $753 million charge as the drugmaker reevaluated the worth of its Alexion acquisition.
AstraZeneca Cambridge Biomedical Campus aerial

AZ eyes China's explosion of innovation for cell therapy

May 21, 2024 8:27am
Pascal Soriot

AstraZeneca COVID-19 vaccine data hint at single-dose efficacy

Dec 9, 2020 7:40am
Pascal Soriot

AstraZeneca nears temporary OK for COVID-19 vaccine

Nov 30, 2020 4:46am
Pascal Soriot

AstraZeneca COVID-19 vaccine on track for 2020 filing: Soriot

Sep 10, 2020 8:25am
IFPMA media briefing COVID

COVID-19 vaccine leaders talk need for speed, partners

May 29, 2020 6:40am